Chronic fatigue syndrome is a condition of unknown etiology characterized by severe fatigue and accompanied by symptoms including cognitive difficulties, myalgias, and headaches. Studies of this illness have found chronic activation of the immune system, including one reporting elevated levels of eosinophil cationic protein, considered an eosinophil activation marker. The aim of this study was to measure serum levels of eosinophil protein X, a cationic protein not measured previously in this illness. Measurements are reported on serum samples from 29 patients meeting the Centers for Disease Control and Prevention criteria for chronic fatigue syndrome, and 30 healthy controls of similar age and gender. The median serum eosinophil protein X level in patients was higher than controls: 37.9 vs. 25.3μg/L (p = 0.037). Forty-eight percent of patients versus 23% of controls had levels above the normal range. The marked increase in serum levels of eosinophil protein X in chronic fatigue syndrome patients could reflect eosinophil activation in this illness. Read More: http://informahealthcare.com/doi/abs/10.1300/J092v09n01_03
Increased eosinophil protein x levels in chronic fatigue syndrome / R. s., Shacterle; Richard, Schacterle; Conti, Fabrizio; Leonardo, Magrini; Anthony, Komaroff; Valesini, Guido. - In: JOURNAL OF THE CHRONIC FATIGUE SYNDROMES. - ISSN 1057-3321. - STAMPA. - 9:1-2(2001), pp. 21-30. [10.1300/j092v09n01_03]
Increased eosinophil protein x levels in chronic fatigue syndrome
CONTI, FABRIZIO;VALESINI, Guido
2001
Abstract
Chronic fatigue syndrome is a condition of unknown etiology characterized by severe fatigue and accompanied by symptoms including cognitive difficulties, myalgias, and headaches. Studies of this illness have found chronic activation of the immune system, including one reporting elevated levels of eosinophil cationic protein, considered an eosinophil activation marker. The aim of this study was to measure serum levels of eosinophil protein X, a cationic protein not measured previously in this illness. Measurements are reported on serum samples from 29 patients meeting the Centers for Disease Control and Prevention criteria for chronic fatigue syndrome, and 30 healthy controls of similar age and gender. The median serum eosinophil protein X level in patients was higher than controls: 37.9 vs. 25.3μg/L (p = 0.037). Forty-eight percent of patients versus 23% of controls had levels above the normal range. The marked increase in serum levels of eosinophil protein X in chronic fatigue syndrome patients could reflect eosinophil activation in this illness. Read More: http://informahealthcare.com/doi/abs/10.1300/J092v09n01_03| File | Dimensione | Formato | |
|---|---|---|---|
|
Schacterle_Increasead_2001.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
269.16 kB
Formato
Adobe PDF
|
269.16 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


